Xiaona Fan
Beijing, 100020, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Targeting enolase isoenzyme 2 enables precision glycolysis inhibition in VHL-mutant renal cell carcinoma.
Journal: Cell death & disease
Published: December 13, 2025
Unraveling p-Cresol: from biosynthesis to biological and biochemical activities.
Journal: Frontiers in pharmacology
Published: July 21, 2025
Hypoxic stimulation of DCLK1 transcription and alternative-promoter switching fuels tumor malignancy in clear cell renal cell carcinoma.
Journal: Cell death & disease
Published: November 25, 2024
Restoration of A2M reduces drug resistance and malignancy in paclitaxel-resistant lung cancer cells.
Restoration of A2M reduces drug resistance and malignancy in paclitaxel-resistant lung cancer cells.
Journal: The international journal of biochemistry & cell biology
Published: November 04, 2024
A targetable MYBL2-ATAD2 axis governs cell proliferation in ovarian cancer.
Journal: Cancer gene therapy
Published: May 19, 2022
Facile purification of active recombinant mouse cytosolic carboxypeptidase 6 from Escherichia coli.
Journal: Protein expression and purification
Published: March 08, 2022
Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma.
Journal: Frontiers in oncology
Published: September 02, 2021
Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal adenocarcinoma.
Journal: Translational oncology
Published: August 23, 2021
Inhibition of DCLK1 sensitizes resistant lung adenocarcinomas to EGFR-TKI through suppression of Wnt/β-Catenin activity and cancer stemness.
Journal: Cancer letters
Published: August 11, 2021
DCLK1 Suppresses Tumor-Specific Cytotoxic T Lymphocyte Function Through Recruitment of MDSCs via the CXCL1-CXCR2 Axis.
Journal: Cellular and molecular gastroenterology and hepatology
Published: July 15, 2021
Combination of anlotinib and gemcitabine promotes the G0/G1 cell cycle arrest and apoptosis of intrahepatic cholangiocarcinoma in vitro.
Journal: Journal of clinical laboratory analysis
Published: June 05, 2021
DCLK1-Short Splice Variant Promotes Esophageal Squamous Cell Carcinoma Progression via the MAPK/ERK/MMP2 Pathway.
Journal: Molecular cancer research : MCR
Published: March 05, 2021
Last Updated: 09/26/2026